In terms of applied research with a particular kind of commercializable outcome, certainly there are better and worse ways of doing that in terms of partnerships. Certainly, we'd want to see partnerships that protect academic freedom and protect scientific inquiry as distinct from the aims of the private company.
I think a bigger issue in terms of our need for research funding is that we're seeing basic investigator-led research really dwindle in favour of this more applied research. This is not to say it's not needed, but we're seeing a shift in the balancing of those two streams.
Obviously, we're coming out of a pandemic, and it's often been said that if we funded only applied research, we might have the best iron lung in the world, but we wouldn't have a polio vaccine. That's really a good point for where we are now. We want to look to solutions and partnerships with industry, and sometimes that can be part of the solution, but it doesn't make up for the gap in basic investigator-led research.